| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/20/2008 | EP1890151A1 Oncolytic viruses as phenotyping agents for neoplasms |
| 02/20/2008 | EP1889914A1 Compositions for gene therapy of diabetes |
| 02/20/2008 | EP1889627A1 Therapeutic agent for blood-related disease containing epo derivative |
| 02/20/2008 | EP1889547A2 A food composition and method of using same |
| 02/20/2008 | EP1888741A2 Treatment of ischemia using stem cells |
| 02/20/2008 | EP1888123A2 A cellular therapy for ocular degeneration |
| 02/20/2008 | EP1888099A2 Hydratable keratin compositions |
| 02/20/2008 | EP1888090A1 Transfer factor preparations and associated methods |
| 02/20/2008 | EP1888088A1 Bacterial management in animal holding systems |
| 02/20/2008 | EP1888087A1 Ethanolic extract of animal origin combined with enzymes acts therapeutically on malignant and other diseases. |
| 02/20/2008 | EP1888086A2 Stable dairy components effective for fat loss |
| 02/20/2008 | EP1888055A2 Fish oil in stabilized form |
| 02/20/2008 | EP1887967A2 Dermal fillers for biomedical applications in mammals and methods of using the same |
| 02/20/2008 | EP1753440B1 Oral form of administration containing probiotic bacteria |
| 02/20/2008 | EP1333846A4 Preparation and xenotransplantation or porcine islets |
| 02/20/2008 | EP1218028B1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific t cell responses |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0837687B1 Hapten modified tumor cell extract and methods of treating cancer |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128598A Methods of producing influenza vaccine compositions |
| 02/20/2008 | CN101128597A Use of an agent produced from a parasite for prevention and control of diseases |
| 02/20/2008 | CN101128578A Method of inducing differentiation of skeletal muscle cell |
| 02/20/2008 | CN101128208A Formulations and treatments for trichology |
| 02/20/2008 | CN101128182A Heavy chain and domain antibodies |
| 02/20/2008 | CN101128122A Fermented tea beverage and tea beverage |
| 02/20/2008 | CN101126079A Storage method for melanin cell suspension |
| 02/20/2008 | CN101126076A TGF-beta induced adjustment T cell and its forming method and application |
| 02/20/2008 | CN101125196A External applied medicine for treating lumbar vertebra, cervical vertebra and osteoarthrilis |
| 02/20/2008 | CN101125193A Suppository for eliminating vagina diseases |
| 02/20/2008 | CN101125192A Granule preparation for preventing and treating viral hepatitis associated with liver blood stasis |
| 02/20/2008 | CN101125191A Traditional Chinese medicine composition for curing non-gonococcal urethritis |
| 02/20/2008 | CN101125187A Traditional Chinese medicinal plaster for treating pulmonary tuberculosis |
| 02/20/2008 | CN101125186A Chinese medicine for treating prostatitis |
| 02/20/2008 | CN101125183A Spleen-invigorating stomach-protecting granule medicine |
| 02/20/2008 | CN101125181A Plaster for treating facial neuroparalysis |
| 02/20/2008 | CN101125180A Traditional Chinese medicine for curing rheumatism |
| 02/20/2008 | CN101125178A Traditional Chinese medicine for treating tumor |
| 02/20/2008 | CN101125177A Fermented glutinous wine for treating diabetes |
| 02/20/2008 | CN101125176A Medicine for curing psoriasis |
| 02/20/2008 | CN101125173A Traditional Chinese medicine 'guiyuantangkang' for treating diabetes and its complication |
| 02/20/2008 | CN101125170A Gastric floating composition for sobering up |
| 02/20/2008 | CN101125166A External-applied traditional Chinese medicine for treating rheumatism |
| 02/20/2008 | CN101125165A Traditional Chinese medicine for treating deaf |
| 02/20/2008 | CN101125161A Burn cream for treating burn and scald and its preparation method |
| 02/20/2008 | CN101125151A Bacteroides signal molecule microecological preparation and its preparation method |
| 02/20/2008 | CN100370252C Method for controlling quality of injection liquid or powder of |
| 02/20/2008 | CN100370019C Lactobacillus plantarum CW006 with antihypertensive function |
| 02/20/2008 | CN100369633C Method for inactivation of microorganisms using photosensitizers |
| 02/20/2008 | CN100369630C Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 02/20/2008 | CN100369625C Externally applied medicinal ointment for treating scald and burn |
| 02/20/2008 | CN100369617C Chinese medicine composition and its application in health pillow and health pillow |
| 02/20/2008 | CN100369612C External-use powder medicine for wetting burn and empyrosis and its preparing method |
| 02/20/2008 | CN100369609C Compound dired Chinese forest frog oil capsule and its preparation |
| 02/20/2008 | CN100369603C Product recipe for bee glue soft capsule inclusion |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332648 Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates |
| 02/19/2008 | US7332577 Active antithrombin content ranging from 0.03 to 0.10 mg/g of albumin, and a prekallikrein (PKA) activity that remains below 35 IU/ml over time; to increase blood volume in cardiovascular surgery |
| 02/19/2008 | US7332336 Methods for inducing differentiation of pluripotent cells |
| 02/19/2008 | US7332334 Hematopoietic stem cells treated by in vitro fucosylation and methods of use |
| 02/19/2008 | US7332332 Mixture comprising sodium and potassium ions for use in transfer of exogenous nucleotide sequences into cells; genetic engineering and heterologous gene expression |
| 02/19/2008 | US7332321 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product |
| 02/19/2008 | US7332168 Composition for the elimination of autoreactive B-cells |
| 02/19/2008 | US7332158 Compositions and treatments for myelosuppression by ex vivo activated immune cells |
| 02/19/2008 | US7332157 Methods for human allografting |
| 02/19/2008 | CA2413844C The effect of a buffering agent on acidogenesis of plaque |
| 02/19/2008 | CA2310400C Novel physiologically active substance sulphostin, process for producing the same, and use thereof |
| 02/19/2008 | CA2273848C Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2206670C Heat treated blood plasma proteins |
| 02/14/2008 | WO2008019379A2 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 02/14/2008 | WO2008019024A2 Bone graft composites and methods of treating bone defects |
| 02/14/2008 | WO2008018450A1 Cell preparation containing multipotential stem cells originating in fat tissue |
| 02/14/2008 | WO2008018190A1 Fat-derived neural crest cells |
| 02/14/2008 | WO2008018143A1 Moisturizing agent |
| 02/14/2008 | US20080039955 Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
| 02/14/2008 | US20080039535 Methods of identifying agents for treating neurological disorders |
| 02/14/2008 | US20080039396 Freeze drying an aliquot of an aqueous solution blood factor such as antihemophilic factor or blood-coagulation factor IX in the presence of trehalose stabilizer wherein the aliquot is free of albumin; hemophilia treatment |
| 02/14/2008 | US20080039390 Use of the insulin-like-growth factor I splice variant MGF for the prevention of myocardial damage |
| 02/14/2008 | US20080039370 Stable Oxidation Resistant Powdered Hemoglobin, Methods of Preparing Same, and Uses Thereof |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080039363 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production |
| 02/14/2008 | US20080038822 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/14/2008 | US20080038819 Micro Rna Inhibiting the Expression of Wt1 Gene and Utilization of the Same |
| 02/14/2008 | US20080038352 Electroprocessed Collagen and Tissue Engineering |
| 02/14/2008 | US20080038337 Smectite DispersibleTablets and the Preparation Thereof |
| 02/14/2008 | US20080038322 Stabilized Bacteriophage Formulations |
| 02/14/2008 | US20080038314 Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038296 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 02/14/2008 | US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038253 Methods For Altering T Cell Diversity |
| 02/14/2008 | US20080038240 Using bacillus coagulans inoculation to increase carbohydrate absorption in mammals and reduce symptoms of gastrointestinal distress |
| 02/14/2008 | US20080038239 Method for treating and/or preventing intestinal bacterial imbalance |
| 02/14/2008 | US20080038235 Methods for regulating T cell subsets by modulating transcription factor activity |
| 02/14/2008 | US20080038234 Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair |
| 02/14/2008 | US20080038233 Treatment of Spinal Conditions |
| 02/14/2008 | US20080038231 Processing procedure for peripheral blood stem cells |
| 02/14/2008 | US20080038230 Method Of Cell Isolation |
| 02/14/2008 | US20080038229 Intracoronary injection of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium |